TROP2 identified as a promising therapeutic target for renal medullary carcinoma
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and…
Modifiable risk factors could double global kidney cancer cases by 2050
Modifiable risk factors such as obesity, smoking, lack of exercise, diabetes and hypertension are projected to be one…